Ark Biosciences

OverviewSuggest Edit

Ark Biosciences (爱科百发生物医药是) is a company that specializes in antiviral and respiratory drug development. It aims to provide treatments for a chronic obstructive pulmonary disease (COPD), respiratory syncytial virus (RSV), idiopathic pulmonary fibrosis (IPF) as well as hepatitis B virus (HBV).

TypePrivate
Founded2014
HQCN
Websitearkbiosciences.com

Locations

Ark Biosciences is headquartered in
China

Location Map

Latest Updates

Employees (est.) (Jun 2021)4(-20%)
Cybersecurity ratingBMore

Key People/Management at Ark Biosciences

Haiqing Yuan

Haiqing Yuan

Chief Science Officer
Jim Wu

Jim Wu

founder and CEO
Show more

Ark Biosciences Office Locations

Ark Biosciences has an office in
Show all (1)

Ark Biosciences Financials and Metrics

Summary Metrics

Founding Date

2014

Ark Biosciences total Funding

$40 m

Ark Biosciences latest funding size

$32 m

Time since last funding

3 years ago

Ark Biosciences investors

Ark Biosciences's latest funding round in June 2018 was reported to be $32 m. In total, Ark Biosciences has raised $40 m
Show all financial metrics

Ark Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Ark Biosciences Online and Social Media Presence

Embed Graph

Ark Biosciences Frequently Asked Questions

  • When was Ark Biosciences founded?

    Ark Biosciences was founded in 2014.

  • Who are Ark Biosciences key executives?

    Ark Biosciences's key executives are Haiqing Yuan and Jim Wu.

  • How many employees does Ark Biosciences have?

    Ark Biosciences has 4 employees.

  • Who are Ark Biosciences competitors?

    Competitors of Ark Biosciences include Strides Pharma, LFB and Cadila Pharmaceuticals.

  • Where are Ark Biosciences offices?

    Ark Biosciences has an office in.

  • How many offices does Ark Biosciences have?

    Ark Biosciences has 1 office.